Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Tweed_Marijuana_Inc.
|
| gptkbp:advocates_for |
Some medical professionals
|
| gptkbp:appointed_by |
gptkb:engine
Tinctures Edibles Topicals Vapor |
| gptkbp:contains |
gptkb:CBD
gptkb:THC |
| gptkbp:developed_by |
gptkb:Cannabis_indica
gptkb:Cannabis_ruderalis Cannabis sativa |
| gptkbp:has_impact_on |
gptkb:Mental_health
Chronic pain Sleep disorders |
| https://www.w3.org/2000/01/rdf-schema#label |
Medical Cannabis
|
| gptkbp:is_associated_with |
Alternative medicine
Holistic health Cannabinoid therapy |
| gptkbp:is_available_on |
Prescription medication
Over-the-counter products |
| gptkbp:is_challenged_by |
Drug enforcement agencies
Some politicians |
| gptkbp:is_considered_as |
Patients with chronic conditions
Patients seeking alternative treatments |
| gptkbp:is_criticized_for |
gptkb:legislation
Social stigma Health risks |
| gptkbp:is_discussed_in |
Public forums
Legislative sessions Medical journals |
| gptkbp:is_evaluated_by |
Clinical trials
|
| gptkbp:is_influenced_by |
gptkb:legislation
gptkb:Public_opinion |
| gptkbp:is_linked_to |
Improved quality of life
Increased patient satisfaction Reduced opioid use |
| gptkbp:is_opposed_by |
Some health organizations
|
| gptkbp:is_part_of |
Cannabis culture
Medical treatment plans |
| gptkbp:is_promoted_by |
Advocacy groups
Health campaigns Public education initiatives |
| gptkbp:is_studied_in |
Potential benefits
Potential side effects |
| gptkbp:is_subject_to |
Research studies
|
| gptkbp:is_used_for |
gptkb:Nausea
Pain relief Appetite stimulation |
| gptkbp:is_used_in |
gptkb:cemetery
Cancer treatment Multiple sclerosis treatment HIV/ AIDS treatment Epilepsy treatment |
| gptkbp:legal_issue |
Some countries
Some states in the USA |
| gptkbp:regulates |
Health authorities
|